IL HB2440

INS CD-PRESCRIPTION DRUG PRICE

Introduced House Mary Canty (D)
Plain English Summary

Illinois HB2440 requires health insurers and pharmacy benefit managers to inform patients about any changes in prescription drug coverage or pricing. It also mandates that they establish a process for patients to appeal these changes or request exceptions, ensuring that patients can provide evidence for their cases. The Department of Insurance will oversee these processes and can enforce changes if they are found to be inadequate.

Supporters Say

Supporters of HB2440 would argue that this bill enhances transparency and accountability in the healthcare system, empowering patients to advocate for their needs regarding prescription drug coverage. By requiring clear communication and a structured appeal process, the bill aims to protect patients from unexpected changes that could impact their access to necessary medications.

Critics Say

Critics of HB2440 might contend that the bill could impose additional burdens on pharmacy benefit managers and health insurers, potentially leading to increased administrative costs that could be passed on to consumers. They may also argue that the appeal process could complicate and delay access to medications, ultimately hindering timely care for patients who rely on prescription drugs.

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us

About This Analysis

This summary was generated using AI from the bill's official text and metadata. Data sourced from LegiScan and the Illinois General Assembly. Conflict-of-interest analysis for this bill is coming soon.